The Efficacy of Moclobemide in Treatment of Major Depression
The effectiveness and the tolerence of moclobemde -one of the reversible inhibitors of MAO-A were assessed in an open clinical trial on 19 inpatients with major depression according to DSM.III and with a score of 16 or more on Hamilton Rating Scale of Depression (HRSD). As a result, a statistically...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Mesut Çetin
2021-03-01
|
| Sarja: | Psychiatry and Clinical Psychopharmacology |
| Aiheet: | |
| Linkit: | https://psychiatry-psychopharmacology.com/index.php/pub/article/view/106 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|